Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell and spatial architecture of primary liver cancer.
Zhou PY, Zhou C, Gan W, Tang Z, Sun BY, Huang JL, Liu G, Liu WR, Tian MX, Jiang XF, Wang H, Tao CY, Fang Y, Qu WF, Huang R, Zhu GQ, Huang C, Fu XT, Ding ZB, Gao Q, Zhou J, Shi YH, Yi Y, Fan J, Qiu SJ. Zhou PY, et al. Among authors: huang jl, huang r, huang c. Commun Biol. 2023 Nov 20;6(1):1181. doi: 10.1038/s42003-023-05455-0. Commun Biol. 2023. PMID: 37985711 Free PMC article.
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, Tian M, Tao C, Huang R, Zhu G, Jiang X, Gao J, Qu W, Wang H, Zhou P, Wu X, Jin L, Sun H, Ding Z, Peng Y, Zhao S, Zhou J, Fan J, Xu W, Shi Y. Fang Y, et al. Among authors: huang r. Hepatology. 2023 Jan 1;77(1):109-123. doi: 10.1002/hep.32348. Epub 2022 Feb 7. Hepatology. 2023. PMID: 35043976
MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL, Wang B, Wu ML, Li J, Gong RM, Song LN, Zhang HS, Zhu GQ, Chen SP, Cai JL, Xing XX, Wang YD, Yang Y, Cai CZ, Huang R, Liu H, Dai Z. Wan JL, et al. Among authors: huang r. Cancer Lett. 2022 Aug 10;541:215750. doi: 10.1016/j.canlet.2022.215750. Epub 2022 May 21. Cancer Lett. 2022. PMID: 35609735
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Qu WF, Ding ZB, Qu XD, Tang Z, Zhu GQ, Fu XT, Zhang ZH, Zhang X, Huang A, Tang M, Tian MX, Jiang XF, Huang R, Tao CY, Fang Y, Gao J, Wu XL, Zhou J, Fan J, Liu WR, Shi YH. Qu WF, et al. Among authors: huang r, huang a. BJS Open. 2022 Sep 2;6(5):zrac114. doi: 10.1093/bjsopen/zrac114. BJS Open. 2022. PMID: 36125345 Free PMC article.
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.
Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, Tao CY, Gao J, Wu XL, Sun HX, Zhou YF, Song SS, Ding ZB, Dai Z, Zhou J, Ye D, Wu DJ, Liu WR, Fan J, Shi YH. Zhu GQ, et al. Among authors: huang r. Cell Discov. 2023 Mar 6;9(1):25. doi: 10.1038/s41421-023-00529-z. Cell Discov. 2023. PMID: 36878933 Free PMC article.
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.
Qu WF, Tian MX, Lu HW, Zhou YF, Liu WR, Tang Z, Yao Z, Huang R, Zhu GQ, Jiang XF, Tao CY, Fang Y, Gao J, Wu XL, Chen JF, Zhao QF, Yang R, Chu TH, Zhou J, Fan J, Yu JH, Shi YH. Qu WF, et al. Among authors: huang r. Hepatol Int. 2023 Aug;17(4):927-941. doi: 10.1007/s12072-023-10511-2. Epub 2023 Apr 8. Hepatol Int. 2023. PMID: 37031334 Free PMC article.
12,702 results
You have reached the last available page of results. Please see the User Guide for more information.